Urine Cytology Market Size was valued at USD 0.99 Billion in 2023. The Global Urine Cytology industry is projected to grow from USD 1.10 Billion in 2024 to USD 2.40 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.03% during the forecast period (2024 - 2032).
Cytology is an emerging field in healthcare that plays an important role in the diagnosis of various diseases such as cancer, and chronic diseases. It involves the examination of cells of the body under a microscope. In urine cytology, urine specimen is collected from the patient to determine the functioning of the cells. The healthcare provider may recommend urine cytology examination if the patient has symptoms such as unexplained blood in the urine, burning and pain during urination. It is commonly used for the diagnosis of infection, inflammatory disease of the urinary tract, cancer of kidney, bladder, ureter, urethra, and others.
Rising prevalence of chronic diseases such as urinary tract infection, and cancer, increasing demand for urine tests, and the presence of key players in the market are important drivers that accelerate the growth of the market. Increasing demand for testing kits for home care is another key driver for the market growth. Additionally, increasing focus on diagnostic services in both the developing and developed regions across the globe also influences the growth of the market. Furthermore, replacement of manual instruments by automated ones in the hospitals and diagnostic centers also fuels the progress of the market. Although competition among key players in the market may act as a barrier for new entrants.
On the basis of product, market is segmented into urine cytology instrument, urine cytology kit, and others. Product is further segmented into automated, and manual instrument.
On the basis of indication, the market is segmented into urinary infection, inflammatory disease, cancer, and others. Cancer is further segmented into kidney, bladder, ureter, and urethra.
On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, home care, and others.
America acquires a leading position in the market for urine cytology, owing to the rising prevalence of various urinary tract infection, inflammatory disease, and cancer. Additionally, presence of key players manufacturing urine urology kits, and devices. The major players are engaged in various strategic approaches such as merger, acquisition, partnership, collaborations, and new product, and others to strengthen their position in the market. ThermoFischer Scientific, BD, and Sigma- Aldrich are 3 major players in the U.S. market.
Europe is the second largest market for urine cytology owing to the availability of funds for research and development activities. Also, rising prevalence of cancer, increasing demand for diagnostic services and rising awareness about urine cytology for the diagnosis of diseases for urinary tract the market growth.
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising prevalence of urinary tract infection which would act as a major risk factor for the growth of the market. Furthermore, rising awareness about the use of urine cytology for the diagnosis of urinary tract infection also influences the growth of the market. Additionally, changing lifestyle and rising geriatric population also drive the growth of the market. Furthermore, rising expenditure on healthcare by the developing countries in Asia Pacific also fuels the growth of the market.
The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic diseases such as infection, and cancer and improving healthcare infrastructure. The United Arab Emirates, and Saudi Arabia are the largest contributors to the growth of the market owing to the availability of specialty healthcare resources and demand for diagnostics devices, and test kits. Increasing demand for new treatment options for chronic diseases also influences the market growth in the Middle East & African countries. In Africa, the market shows positive growth owing to increasing prevalence of infectious diseases and demand for healthcare services in the developing and under developing countries.
Key Players in the Global Urine Cytology Market
Some of the key players in this market are ThermoFischer Scientific (U.S.), BD (U.S.), Sigma- Aldrich (U.S.), Severn Biotech Limited (U.K), Bio-Techne (U.S), Laboratory Corporation of America Holdings (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and others.
Research Methodology
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | USD 2.40 Billion |
| CAGR | 9.03% (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product, By Indication, By End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | ThermoFischer Scientific (U.S.), BD (U.S.), Sigma- Aldrich (U.S.), Severn Biotech Limited (U.K), Bio-Techne (U.S), Laboratory Corporation of America Holdings (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and others. |
| Key Market Opportunities | Increased public awareness and government-led screening initiatives can drive market growth. |
| Key Market Drivers | Increasing cases of bladder and urinary tract cancers boost the demand for urine cytology as a non-invasive diagnostic method. |
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
